Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Zollinger-Ellison Syndrome × YF 476 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Gastroesophageal Reflux 2 Barrett Esophagus 2 Zollinger-Ellison Syndrome 1 Adenocarcinoma Of Esophagus 1

Interventions

Temozolomide 2 Omeprazole 2 Lansoprazole 2 Esomeprazole 2 Capecitabine 2 veliparib 1 pazopanib 1 cixutumumab 1 YF 476 1 Streptozocin 1 Salts 1 Pantoprazole 1 Octreotide 1 Interferons 1 Fluorouracil 1 Everolimus 1 Doxorubicin 1 Dexlansoprazole 1 Clopidogrel 1 Acetates 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02454075 2021-01-29

YF476 and Type II Gastric Carcinoids

Trio Medicines Ltd.

Phase 2 Terminated

3 enrolled 11 charts

Zollinger-Ellison Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡